UnitedHealth Group has announced a deal to acquire Catamaran Corporation for $12.8 billion which would improve their market position in benefits management segment and add to their negotiating power with drug makers. The pharmacy benefits segment has been in focus as the drug companies are pushed for discounting their high-priced treatment options.
UnitedHealth Group Inc. will pay $61.5 per share for Catamaran Corporation, nearly 27 percent premium to Catamaran’s closing price of $48.3 on Friday. Catamaran stock jumped 24 percent to close at $59.83 after the deal was announced. UnitedHealth will finance the deal with a mix of cash and debt.